COL1A2 and breast carcinoma: On the other hand, several studies based on bioinformatics have revealed a lower survival probability of breast cancer, gastric cancer, mesothelioma, and colorectal cancer patients with higher expression of COL1A1, COL1A2, and COL11A1.79, 80, 81, 82